2010
MASPECTRAS 2: An Integration and Analysis Platform for Proteomic Data.
Ubaida Mohien C,
Hartler J,
Breitwieser F,
Rix U,
Remsing Rix L,
Winter GE,
Thallinger GG,
Bennett KL,
Superti-Furga G,
Trajanoski Z,
Colinge J.
Proteomics. 2010 Jul;10(14):2719-22.
2010
BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib.
Sherbenou DW,
Hantschel O,
Kaupe I,
Willis S,
Bumm T,
Turaga LP,
Lange T,
Dao KH,
Press RD,
Druker BJ,
Superti-Furga G,
Deininger MW.
Blood. 2010 Oct 28;116(17):3278-85. Epub 2010 Jun 2.
2010
Myeloid PTEN promotes inflammation but impairs bactericidal activities during murine pneumococcal pneumonia.
Schabbauer G,
Matt U,
Gunzl P,
Warszawska J,
Furtner T,
Hainzl E,
Elbau I,
Mesteri I,
Doninger B,
Binder BR,
Knapp S.
J Immunol. 2010 Jul 1;185(1):468-76. Epub 2010 May 26.
2010
The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice.
Pedersen TX,
Binder CJ,
Fredrikson GN,
Nilsson J,
Bro S,
Nielsen LB.
Nephrol Dial Transplant. 2010 Aug;25(8):2486-91. Epub 2010 Feb 17.
2010
Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres.
O’Sullivan RJ,
Kubicek S,
Schreiber SL,
Karlseder J.
Nat Struct Mol Biol. 2010 Oct;17(10):1218-25. Epub 2010 Oct 3.
2010
Syntehtic lethality: General principles, utility and detection using genetic screens in human cells.
Nijman SM.
FEBS Lett. 2010 Nov 19.
2010
2010
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer.
Li J,
Rix U,
Fang B,
Bai Y,
Edwards A,
Colinge J,
Bennett KL,
Gao J,
Song L,
Eschrich S,
Superti-Furga G,
Koomen J,
Haura EB.
Nat Chem Biol. 2010 Apr;6(4):291-9. Epub 2010 Feb 28.
2010
Genomic imprinting – an epigenetic gene regulatory model.
Koerner MV,
Barlow DP.
Curr Opin Genet Dev. 2010 Apr;20(2):164-70.Epub 2010 Feb 12. Review.
2010
Update on the role of Toll-like receptors during bacterial infections and sepsis.
Knapp S.
Wien Med Wochenschr. 2010 Mar;160(5-6):107-11.
